Rosetta Genomics Company Profile (NASDAQ:ROSG)

About Rosetta Genomics

Rosetta Genomics logoRosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH). It is marketing and selling over four diagnostic tests based on its microRNA technologies, which include RosettaGX Cancer Origin, mi-LUNG, mi-KIDNEY and RosettaGX Reveal. Its therapeutic pipeline consists of the projects, which include Rimonim Consortium and Magneton Project. It focuses on developing diagnostic assay, RosettaGX Reveal V2. It is also focusing on developing Bladder cancer risk stratification. Its PersonalizeDx is focused on the detection of genomic changes through FISH technology, which helps to detect cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ROSG
  • CUSIP:
Key Metrics:
  • Previous Close: $0.45
  • 50 Day Moving Average: $0.4997
  • 200 Day Moving Average: $0.6751
  • 52-Week Range: $0.41 - $1.60
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.95
  • P/E Growth: -0.0400
  • Market Cap: $9.39M
  • Outstanding Shares: 20,870,000
  • Beta: -5.34
Profitability:
  • Net Margins: -167.32%
  • Return on Equity: -127.01%
  • Return on Assets: -103.27%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 2.70%
  • Quick Ratio: 2.70%
Additional Links:
Companies Related to Rosetta Genomics:

Analyst Ratings

Consensus Ratings for Rosetta Genomics (NASDAQ:ROSG) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.61 (484.59% upside)

Analysts' Ratings History for Rosetta Genomics (NASDAQ:ROSG)
Show:
DateFirmActionRatingPrice TargetDetails
1/6/2017AegisReiterated RatingBuy$3.50View Rating Details
9/7/2016S&P Equity ResearchLower Price Target$0.94 -> $0.82View Rating Details
6/13/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
3/28/2016Barrington ResearchLower Price TargetOutperform$5.00 -> $3.50View Rating Details
(Data available from 3/1/2015 forward)

Earnings

Earnings History for Rosetta Genomics (NASDAQ:ROSG)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/14/2017        
9/26/2016Q216($0.17)($0.16)$2.40 millionViewListenView Earnings Details
5/19/2016Q116($0.16)($0.18)$3.36 million$2.60 millionViewListenView Earnings Details
3/23/2016Q415($0.33)($0.14)$3.60 millionViewListenView Earnings Details
12/1/2015Q315$0.27$2.43 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Rosetta Genomics (NASDAQ:ROSG)
Current Year EPS Consensus Estimate: $-0.7000 EPS
Next Year EPS Consensus Estimate: $-0.4700 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.18)($0.18)($0.18)
Q2 20161($0.17)($0.17)($0.17)
Q3 20161($0.16)($0.16)($0.16)
Q4 20161($0.16)($0.16)($0.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Rosetta Genomics (NASDAQ:ROSG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Rosetta Genomics (NASDAQ:ROSG)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Rosetta Genomics (NASDAQ:ROSG)
DateHeadline
News IconRosetta Genomics Ltd ROSG Medical Equipment Deals and Alliances Profile [Updated: 25012017] Prices from USD $250 (NASDAQ:ROSG)
www.bioportfolio.com - March 1 at 10:14 AM
News IconSell-Side is Saying Buy These Stocks: Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NYSE:HASI) Rosetta ... - Davidson Register (NASDAQ:ROSG)
davidsonregister.com - February 24 at 8:00 AM
businesswire.com logoRosetta Genomics Closes Second Tranche of Previously Announced Private Placement of Convertible Debentures - Business Wire (press release) (NASDAQ:ROSG)
www.businesswire.com - February 24 at 8:00 AM
finance.yahoo.com logoRosetta Genomics Closes Second Tranche of Previously Announced Private Placement of Convertible Debentures (NASDAQ:ROSG)
finance.yahoo.com - February 23 at 7:46 PM
News IconSell-side Consensus Sees Rosetta Genomics Ltd. (NASDAQ:ROSG) Going Where Near-Term? - Aiken Advocate (NASDAQ:ROSG)
aikenadvocate.com - February 23 at 8:19 AM
News IconRosetta Genomics Ltd ROSG Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:ROSG)
www.bioportfolio.com - February 15 at 1:13 AM
News IconRosetta Genomics Ltd. (NASDAQ:ROSG) Repros Therapeutics Inc. (NASDAQ:RPRX) Are On Analyst's Buy List - Rives Journal (NASDAQ:ROSG)
rivesjournal.com - February 14 at 6:04 AM
finance.yahoo.com logoRosetta Genomics Reports Preliminary RosettaGX Reveal™ Financial Results for the 2016 Fourth Quarter and Year (NASDAQ:ROSG)
finance.yahoo.com - February 8 at 11:30 PM
finance.yahoo.com logo8:03 am Rosetta Genomics: USPTO has granted two patents, both divisional patents of the parent application titled 'microRNAs and uses thereof' (NASDAQ:ROSG)
finance.yahoo.com - February 6 at 7:41 PM
businesswire.com logoRosetta Genomics Announces Key U.S. Patent Allowances for Two RosettaGx Reveal TM microRNAs (NASDAQ:ROSG)
www.businesswire.com - February 6 at 8:43 AM
finance.yahoo.com logoRosetta Genomics Announces Key U.S. Patent Allowances for Two RosettaGx RevealTM microRNAs (NASDAQ:ROSG)
finance.yahoo.com - February 6 at 8:43 AM
investornewswire.com logoSales Estimates Of Rosetta Genomics Ltd. (NASDAQ:ROSG) At $28.77 - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - February 4 at 7:39 PM
4-traders.com logoNetworkNewsBreaks – Rosetta Genomics Ltd. (NASDAQ: ROSG) Sets Stage for Value Creation in 2017 (NASDAQ:ROSG)
www.4-traders.com - January 20 at 11:04 PM
News IconRosetta Genomics Ltd ROSG Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:ROSG)
www.bioportfolio.com - January 14 at 7:38 PM
News IconAegis Restates ‘Buy’ Rating on Shares of Rosetta Genomics Ltd. (NASDAQ: ROSG) (NASDAQ:ROSG)
missionir.com - January 12 at 2:50 AM
finance.yahoo.com logoAegis Restates 'Buy' Rating on Shares of Rosetta Genomics Ltd. (NAS:ROSG) (NASDAQ:ROSG)
au.finance.yahoo.com - January 11 at 9:49 PM
marketexclusive.com logoAnalyst Activity – Aegis Reiterates Buy on Rosetta Genomics (NASDAQ:ROSG) (NASDAQ:ROSG)
marketexclusive.com - January 8 at 12:18 AM
finance.yahoo.com logoRosetta Genomics Reports Third Quarter 2016 Financial Results (NASDAQ:ROSG)
finance.yahoo.com - December 20 at 2:19 PM
investornewswire.com logoRosetta Genomics Ltd. (NASDAQ:ROSG) Sales Anticipated At $25.27 - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - December 18 at 7:57 PM
News IconMulticentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears (NASDAQ:ROSG)
jcp.bmj.com - December 8 at 8:01 PM
reuters.com logoBRIEF-Rosetta Genomics files for resale of up to 15.5 mln of co's ordinary shares by selling stockholders (NASDAQ:ROSG)
www.reuters.com - December 8 at 8:01 PM
News IconCan This Stock Gain Traction: Rosetta Genomics, Ltd. (NASDAQ:ROSG) - Prospect Journal (NASDAQ:ROSG)
prospectjournal.com - December 6 at 8:54 AM
News IconThis Weeks Target Prices For Rosetta Genomics Ltd. (ROSG) - NewsDen (NASDAQ:ROSG)
newsden.net - December 3 at 6:39 PM
finance.yahoo.com logoRosetta Genomics to Present at the 9th Annual LD Micro Main Event (NASDAQ:ROSG)
finance.yahoo.com - December 1 at 8:15 AM
biz.yahoo.com logoQ3 2016 Rosetta Genomics Ltd Earnings Release - After Market Close (NASDAQ:ROSG)
biz.yahoo.com - November 30 at 12:42 PM
News IconRosetta Genomics, Ltd. ROSG Product Pipeline Analysis, 2016 Update Prices from USD $750 (NASDAQ:ROSG)
www.bioportfolio.com - November 25 at 7:04 PM
News IconRosetta Genomics Ltd. (ROSG) Valuation According To Analysts - UK Market News (NASDAQ:ROSG)
www.ukmarketnews.co.uk - November 24 at 7:13 PM
News IconStock to Watch: Rosetta Genomics Ltd. (ROSG) - MicroCap Wired (NASDAQ:ROSG)
www.microcapwired.com - November 24 at 7:13 PM
4-traders.com logoRosetta Genomics USA : Announces Pricing of $5 Million Concurrent Registered Direct and Private Placement Offering (NASDAQ:ROSG)
www.4-traders.com - November 24 at 10:35 AM
streetinsider.com logoRosetta Genomics (ROSG) Prices of $5M Concurrent Registered Direct and Private Placement (NASDAQ:ROSG)
www.streetinsider.com - November 24 at 10:34 AM
streetinsider.com logoRosetta Genomics (ROSG) Prices of $5M Concurrent Registered Direct and Private Placement - StreetInsider.com (NASDAQ:ROSG)
www.streetinsider.com - November 23 at 7:29 PM
publicnow.com logoRosetta Genomics Announces Pricing of $5 Million Concurrent Registered Direct and Private Placement Offering (NASDAQ:ROSG)
www.publicnow.com - November 23 at 7:29 PM
streetinsider.com logoRosetta Genomics (ROSG), Sheba Medical Center Enter MicroRNA-Based BiomarkerResearch Collaboration - StreetInsider.com (NASDAQ:ROSG)
www.streetinsider.com - November 22 at 7:25 PM
News IconWonder Stock Alert: Investors Curious About Rosetta Genomics, Ltd. (NASDAQ:ROSG) - Duncan Research (NASDAQ:ROSG)
www.duncanindependent.com - November 22 at 7:25 PM
businesswire.com logoRosetta Genomics Enters Research Collaboration using microRNA Biomarkers to Predict Response to Leading Immuno-Oncology Drug Nivolumab in Lung Cancer Patients (NASDAQ:ROSG)
www.businesswire.com - November 21 at 12:37 PM
News IconRosetta Genomics, Ltd. ROSG Financial and Strategic SWOT Analysis Review Prices from USD $300 (NASDAQ:ROSG)
www.bioportfolio.com - November 20 at 11:18 AM
News IconFollowing the Indicators: Reviewing Levels on Shares of Rosetta Genomics Ltd. (ROSG) - MicroCap Wired (NASDAQ:ROSG)
www.microcapwired.com - November 17 at 6:55 PM
News IconPenny Stock Making Waves: Taking a Second Look at Rosetta Genomics, Ltd. (NASDAQ:ROSG) - Duncan Research (NASDAQ:ROSG)
www.duncanindependent.com - November 17 at 6:55 PM
News IconBroker Review: Rosetta Genomics Ltd. (ROSG) - UK Market News (NASDAQ:ROSG)
www.ukmarketnews.co.uk - November 17 at 11:23 AM
News IconChecking Moving Average and RSI Levels on Rosetta Genomics Ltd. (ROSG) - MicroCap Wired (NASDAQ:ROSG)
www.microcapwired.com - November 15 at 7:48 PM
investornewswire.com logoRosetta Genomics Ltd. (NASDAQ:ROSG) Expects Sales Of $25.27 - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - November 11 at 6:58 PM
News IconMarket Corner: Eye on Technicals for Rosetta Genomics Ltd. (ROSG) - MicroCap Wired (NASDAQ:ROSG)
www.microcapwired.com - November 11 at 6:58 PM
News IconPenny Stock News: Looking Closer At Rosetta Genomics, Ltd. (NASDAQ:ROSG) - Duncan Research (NASDAQ:ROSG)
www.duncanindependent.com - November 11 at 6:58 PM
News IconTrading Insight: Taking a Look at Levels for Rosetta Genomics Ltd. (ROSG) - MicroCap Wired (NASDAQ:ROSG)
www.microcapwired.com - November 11 at 10:05 AM
News IconPenny Stock Interest: Checking In On Rosetta Genomics, Ltd. (NASDAQ:ROSG) - Duncan Research (NASDAQ:ROSG)
www.duncanindependent.com - November 11 at 10:05 AM
News IconIndicator Level Summary for Rosetta Genomics Ltd. (ROSG) - MicroCap Wired (NASDAQ:ROSG)
www.microcapwired.com - November 8 at 7:01 PM
News IconRosetta Genomics Ltd. (ROSG) – Broker Update - NewsDen (NASDAQ:ROSG)
newsden.net - November 8 at 10:49 AM
investornewswire.com logoExpected For Rosetta Genomics Ltd. (NASDAQ:ROSG) Sales Of $25.27 - Investor Newswire (NASDAQ:ROSG)
www.investornewswire.com - November 4 at 6:46 PM
News IconPenny Stock Update: Looking At Rosetta Genomics, Ltd. (NASDAQ:ROSG) - Duncan Research (NASDAQ:ROSG)
www.duncanindependent.com - November 4 at 6:46 PM
News IconEquity Rundown: RSI and CCI Check on Rosetta Genomics Ltd. (ROSG) - MicroCap Wired (NASDAQ:ROSG)
www.microcapwired.com - November 4 at 10:57 AM

Social

What is Rosetta Genomics' stock symbol?

Rosetta Genomics trades on the NASDAQ under the ticker symbol "ROSG."

Where is Rosetta Genomics' stock going? Where will Rosetta Genomics' stock price be in 2017?

3 brokers have issued 1 year price objectives for Rosetta Genomics' stock. Their forecasts range from $0.82 to $3.50. On average, they expect Rosetta Genomics' stock price to reach $2.61 in the next twelve months.

When will Rosetta Genomics announce their earnings?

Rosetta Genomics is scheduled to release their next quarterly earnings announcement on Tuesday, March, 14th 2017.

How do I buy Rosetta Genomics stock?

Shares of Rosetta Genomics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Rosetta Genomics stock cost?

One share of Rosetta Genomics stock can currently be purchased for approximately $0.45.

Rosetta Genomics (NASDAQ:ROSG) Chart for Wednesday, March, 1, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Rosetta Genomics (NASDAQ:ROSG)

Earnings History Chart

Earnings by Quarter for Rosetta Genomics (NASDAQ:ROSG)

Dividend History Chart

Dividend Payments by Quarter for Rosetta Genomics (NASDAQ:ROSG)

Last Updated on 3/1/2017 by MarketBeat.com Staff